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ORIGINAL ARTICLE
15q13.3 homozygous knockout mouse model display
epilepsy-, autism- and schizophrenia-related phenotypes
A Forsingdal1,2,3, K Fejgin1, V Nielsen1, T Werge2,3,4 and J Nielsen1
The 15q13.3 microdeletion syndrome is caused by a 1.5-MB hemizygous microdeletion located on 15q13.3 affecting seven genes:
FAN1; MTMR10; TRPM1; miR-211; KLF13; OTUD7A; and CHRNA7. The 15q13.3 microdeletion increases the risk of intellectual disability,
epilepsy, autism spectrum disorder and schizophrenia, though the clinical proﬁle varies considerably. Two mouse models of this
syndrome, with hemizygous deletion of the orthologous region in the murine genome, have recently been shown to recapitulate a
number of the behavioral and physiological deﬁcits that characterize the human condition. Still, little is known of the underlying
biological mechanisms. Eleven human cases with homozygous deletion of the 15q13.3 region have been reported, all with severe
functional and physiological impairments. We therefore hypothesized that a 15q13.3 homozygous knockout would confer
more pronounced behavioral and physiological deﬁcits in mice than the 15q13.3 hemizygous deletion. Here we report the
characterization of a 15q13.3 knockout mouse. We observed marked deﬁcits including altered seizure susceptibility, autistic
behavior-related phenotypes, and auditory sensory processing. Several of these deﬁcits, albeit less pronounced, were also found in
the 15q13.3 hemizygous littermates indicating a gene-dosage dependency. Our ﬁndings strongly indicate that studies of the hemi-
and homozygous 15q13.3 mouse strains will facilitate understanding of the biological mechanisms of severe mental disorders.
Translational Psychiatry (2016) 6, e860; doi:10.1038/tp.2016.125; published online 26 July 2016
INTRODUCTION
Decades of intensive research have provided little knowledge and
understanding of the biological changes underlying severe
psychiatric disorders, in particular schizophrenia and autism. One
advancement has come from genome-wide association studies
that identiﬁed hemizygous microdeletions and microduplications
termed copy-number variants (CNVs), which confer high risk of
these disorders.1 The 15q13.3 hemizygous microdeletion increases
the risk of intellectual disability, epilepsy, autism spectrum
disorder and schizophrenia 10-fold or more.2–5 The microdeletion
encompasses a region of ~ 1.5 MB from break-point (BP) 4 to BP5,
with seven genes; MTMR10; FAN1; TRPM1; miR-211; KLF13; OTUD7A;
and CHRNA7 (OMIM #612001). The clinical phenotype varies
greatly among individuals with the 15q13.3 microdeletion,
ranging from asymptomatic to severe neuropsychiatric disorders.
In addition, the microdeletion is present in ~ 1% of patients with
idiopathic generalized epilepsy compared with 0.019% in the
general population.1,4,6 Epileptic carriers that have been pheno-
typed in detail mainly suffer from absence seizures and not from
generalized seizures.7,8
Disorder-associated CNVs provide an opportunity to gain insight
into underlying mechanisms of the pathogenesis. We, and others,
recently generated and characterized mouse models of the 15q13.3
microdeletion syndrome by deleting the orthologous genomic
region on mouse chromosome 7.9,10 Behavioral characterization of
the 15q13.3 mouse models, Df(h15q13)+/− , revealed schizophrenia-,
autism- and epilepsy-related phenotypes.9,10
The 15q13.3 CNV is distinct from most known high-risk CNVs
as relatively few genes are involved, simplifying mechanistic
evaluation. Furthermore, humans with homozygous deletions are
viable, as 11 cases of homozygous deletion of the 15q13.3 region
have been reported, all of them with severe physical and mental
handicaps.11
The viability of humans with homozygous 15q13.3 deletion
suggests that the generation of a homozygous mouse model
for this syndrome is feasible. We hypothesize that a 15q13.3
homozygous mouse model will provide both new and stronger
phenotypes than those previously observed in the hemizygous
mouse models, and that the combined study of wildtype (WT),
hemizygous and homozygous 15q13.3 mouse strains will inform
on the molecular and physiological mechanisms underlying
schizophrenia, autism and epilepsy.
Here we present, to the best of our knowledge, the ﬁrst study of
homozygous 15q13.3 knockout mice, Df(h15q13)− /− mice, in
which we compare Df(h15q13)− /−, Df(h15q13)+/− and WT
littermates. We focus on behavioral assays related to the
neuropsychiatric disorders known to affect human 15q13.3
microdeletion carriers.
MATERIALS AND METHODS
Animals
Df(h15q13)− /− mice were bred by mating Df(h15q13)+/− mice. The
generation of Df(h15q13)+/− mice was described by Fejgin et al.9 At
weaning, when mice were 3 or 4 weeks of age, biopsies were collected for
PCR-based genotyping (see next paragraph). Mice were then split by
gender and group housed (mixed genotypes from the same litter, up to
seven animals per cage), except during the Nest-building assay where
animals were single housed. Mice were bred, genotyped and housed until
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the age of 8 weeks at Taconic MB (Lille Skensved, Denmark), except for the
pups used for ultrasonic vocalization recordings. As the genotype assigned
animals to groups, randomization of animals to experimental groups was
not relevant. At 8 weeks of age, the mice were transferred to the Lundbeck
facility. Animals were housed in Macrolon (type II) cages with standard
sawdust bedding and environmental enrichment (plastic igloo and
wooden chew blocks) in a 12-h light cycle starting at 0600 hours and a
temperature of 21 ± 2 °C; and humidity of 55 ± 5%. Food (Altromin 1323
pills, Brogaarden, Denmark) and tap water were available ad libitum.
Animals were allowed to acclimatize to the facility for at least 5 days before
any test. Experimenters were blinded to the genotype. Testing was
conducted using male and female mice between 10 and 22 weeks of age
unless otherwise stated. All the data shown is from males unless otherwise
stated. Sample sizes for each experiment can be seen in Table 1. Sample
sizes were generally determined by how many homozygous mice could be
bred (and survived). All studies were carried out in accordance with Danish
legislation, granted by the animal welfare committee, appointed by the
Danish Ministry of Food, Agriculture and Fisheries—Danish Veterinary and
Food Administration.
Genotyping and conﬁrmation of gene deletion
PCR was carried out as described in Fejgin et al.9 Tissue was isolated from
whole brain. Total RNA was puriﬁed using the NucleoSpin RNA and Protein
kit according to manufacturer’s instructions (Macherey-Nagel, Düren,
Germany) followed by ﬁrst strand complementary DNA synthesis using
TaqMan reverse transcription reagents according to manufacturer (Life
Technologies, Paisley, UK). Primers designed and validated by Fejgin et al.9
were used. Quantitative PCR was performed on a BioRad C1000 Touch
thermal cycler with a CFX384 optical reaction module using SsoFast
EvaGreen Supermix according to manufacturer (BioRad, Hercules, CA, USA).
Eight reference genes were included of which three were selected (Actb,
Gapdh and H3f3a) for geometric normalization according to geNorm
software version 3.5.12 Transcripts with Cq values 435 were considered
below the detection limit and removed. Genes close to the deleted region
were included for detection of possible effects on bordering genes. The
number of genes upstream and downstream of the deleted region was
increased until transcripts could be detected.
Irwin test
Basic behavioral functions and neurological reﬂexes, such as vision, fear
responses, muscle coordination and so on were tested by a simpliﬁed
version of the original screening described by Irwin.13 We measured: (1)
undisturbed behavioral observation in a small observation cage (following
10-min habituation to the cage)—body position, bizarre behavior
(compulsive/self-bite, circling and head movements) and tremors. (2)
Response to ﬁnger approach (withdrawal and explorative responses to a
slow ﬁnger approach). (3) Touch escape (response to the gentle pressure
over the sides and back of the mouse). (4) Grip strength (resistance of the
animal to pull when holding on a wire-mesh grid). (5) Visual placing
response (animal is lifted vertically by mid-tail about 15 cm above the wire-
mesh grid and lowered slowly to elicit limb extension). (6) Corneal
response (response to the slow approach of a toothpick to the eye, on both
sites). (7) Toe-pinch response (elicited by light compression of the lateral
surface of the mid-digit of each foot with a forceps). (8) Wire-maneuver
(animal is brought to the horizontal wire, allowed to grasp it with its
forelimbs, then released and observed). (9) Limb and abdominal tone
(detected by palpation). (10) Tail-pinch response (response to a moderate
pressure applied with a forceps, ~ 2.5 cm below the base of the tail).
Grip strength
Grip strength was measured using a grip strength meter and peak
ampliﬁer (47105-001 Ugo Basile, Varese, Italy) with a metal wire. Mice were
held by the tail and lowered toward the wire to allow grasping by the
forelimbs. With the body perpendicular to the wire, the mouse was pulled
steadily backwards until the grip was released, and the maximal grip
strength was recorded.
Open ﬁeld
Individual mice were placed in a circular open-ﬁeld arena (74 cm diameter)
for 1 h with low illumination (14 lux). Movement was automatically video
tracked and quantiﬁed using the Ethovision 7.0 software (Noldus
Information Technologies, Wageningen, The Netherlands).
PTZ-induced seizure
To assess seizure susceptibility in the Df(h15q13)− /− mice we scored 4
seizure behaviors after administration of the convulsant drug pentylene
tetrazole (PTZ); (1) early-stage seizures, (2) myoclonic jerks, (3) clonic
seizures and (4) clonic–tonic seizures.9 After the injection of Pentylene
tetrazol (PTZ) (Sigma-Aldrich, Brøndby, Denmark; 40 mg kg− 1, subcuta-
neously), each mouse was observed and video recorded for 30 min by an
observer blinded to genotype. Video recordings were scored using the
Observer software (Noldus Information Technologies). Early-stage seizure
was scored as the ﬁrst four stages of the Racine scale: (1) mouth and facial
movements; (2) head nodding; (3) forelimb clonus; (4) rearing.14
Behavior quantiﬁcation
Animals were placed in separate cages and video recorded for 10 min.
Grooming, digging, rearing, jumping/crawling in the corner of the cage
and crawling in the lid was manually scored and quantiﬁed off-line using
the Observer software (Noldus Information Technologies).
Three-chambered social approach task
The three-chambered social approach task was carried out following the
protocol presented by Yang et al.15 In this test, the mice can move freely
between three chambers; an empty chamber in the middle, a chamber
with an empty cylinder on one side and a chamber with a novel mouse in a
cylinder in the other side. Brieﬂy, the mice were ﬁrst habituated to the
center chamber for 10 min, second, they were habituated to all three
chambers for 10 min. Finally, an empty cylinder was put on one of the side
chambers and a cylinder with a novel mouse was put on the other side
chamber, after which the test for social snifﬁng was carried out for 10 min.
Ultrasonic vocalization
Ultrasonic vocalization was recorded as described by Scattoni et al.16
Pregnant dams were shipped from Taconic to the Lundbeck facility
2 weeks after conception. At postnatal day 6, the pups were put into a
sound-isolated box one by one where vocalization was recorded for 3 min
with an ultrasound microphone (CM16/CMPA, Avisoft Bioacoustics,
Glienicke, Germany) and preampliﬁer (116H, Avisoft Bioacoustics). After
recording, the pup was marked and put back to the dam and littermates.
When all pups had been recorded, tail biopsies were obtained and
genotyped by PCR. Ultrasonic calls were quantiﬁed using the Avisoft-
SASLab Pro software (Avisoft Bioacoustics).
Nest building
Mice were habituated for 2 weeks without nesting material in the home
cages. On the day of testing, mice were divided into single cages with an
igloo with three openings in one corner and a single square of nesting
material (Nestlets, Ancare, Belmont, NY, USA) in the opposite corner of the
cage. Nest building was scored every hour during the ﬁrst 12 h of testing
Table 1. Sample sizes for each experiment
WT +/− − /−
Brain weight 12 — 9
Body weight 17 52 9
Grip strength 6 6 4
Locomotion 11 9 8
Early-stage seizure 7 6 5
Myoclonic jerks 7 6 5
Clonic seizure 7 6 5
Repetitive jumping 13 13 10
Three-chambered social approach 7 6 6
Ultrasonic vocalization 19 53 6
Nest building 8 10 6
Acoustic startle response 11 13 8
Prepulse inhibition 11 13 8
Morris water maze 6 6 4
Cue test (fear conditioning) 9 9 6
Abbreviation: WT, wildtype. +/-, Df(h15q13)+/- mice. -/-, Df(h15q13)-/- mice.
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and after 24 h, using the ‘Nesting Index Score’, (NIS), introduced by
Pedersen et al.17 NIS score has two components: (1) how much nest-
building material is used (0–5 points); (2) how many openings of the igloo
are covered (0–3). Maximal score is 8.
Progressive acoustic startle
Progressive acoustic startle was tested using the SM100 Startle Monitor
System (Kinder Scientiﬁc, Poway, CA, USA), consisting of eight sound-
attenuated startle chambers and StartleMonitor software (Kinder Scien-
tiﬁc). Animals were placed in an adjustable Plexiglas holder, providing
limited movement but not restraint, positioned directly above a sensing
platform registering the animals startle response. Each test session
consisted of a 5-min acclimatization period with only background white
noise (62 dB), followed by startle pulses at intensities varying from 95 to
120 dB, each presented 12 times in a balanced manner. Intertrial intervals
(ITIs) varied between 9 and 21 s (average ITI 15 s). The full acoustic startle
test lasted ~ 25 min.
Prepulse inhibition
Prepulse inhibition (PPI) was tested using the same equipment as for the
progressive acoustic startle test and as described by Fejgin et al.9 Each test
session consisted of a 5-min acclimatization period with only background
white noise (62 dB), followed by a brief habituation setting where 32
regularly occurring startle pulses of 105 dB (ITI: 10 s) were presented to the
animals to maximize habituation prior to the PPI part of the session.
Animals were then subjected to 5 types of trials presented 12 times each in
a balanced manner: pulse alone; prepulse+pulse (5, 10 or 15 dB above
background); or highest prepulse intensity (77 dB) alone. ITI varied
between 9 and 21 s (average ITI 15 s) and interstimulus interval was set
to 100 ms with a prepulse length of 20 ms. Each PPI session ended with
eight startle pulses of 105 dB to estimate habituation across PPI trials. The
full PPI test lasted about 28 min. PPI was calculated as % PPI for each
prepulse intensity as: 100− ((prepulse+pulse/pulse alone) × 100), that is, a
lower percentage score indicates a decrease in PPI. Startle magnitude was
calculated as an average of pulse alone trials.
Morris water maze
The apparatus has been described earlier.18 One week prior to water maze
testing the animals were habituated for 1 min (20 s in 1-cm water and 40 s
of handling) for 5 consecutive days. Animals were subjected to four trials
per day for 6 consecutive days, with ITI of 30 min. Before the ﬁrst trial on
the ﬁrst day, the animals were placed on the platform for 10 s. The ﬁrst trial
started immediately thereafter. During any trial, if the mice did not ﬁnd the
platform they were guided to it and left there for 5 s before being lifted
out of the maze. For each trial, animals started from randomized positions
and were allowed a maximum time of 60 s to ﬁnd the hidden platform
placed in the middle of the northern quadrant.
On the seventh day, a 60-s probe test was performed with the platform
removed, followed by a visual test where the platform was marked with a
visible ﬂag. After each trial, mice were dried with paper towels and allowed
to heat under a heating lamp for 3–4 min before resting in their home
cage. Time spent before ﬁnding the platform was analyzed using the
Ethovision 3.0 software (Noldus).
Contextual and cued fear conditioning
Training and contextual testing was conducted in a sound-proof
chamber (30 × 20 × 40 cm) connected to a ventilation system in an isolated
room. The ﬂoor of the chamber consisted of a metal grid attached to an
electric shock generator. Prior to training and testing, the chamber was
cleaned with 70% ethanol. A video camera was used for recording of
sessions for subsequent off-line analysis. The test program (shock, sound
and light) was run by FCONwin (Ellegaard Systems, Faaborg, Denmark).
The training session lasted 6 min. During the ﬁrst and last minute of the
training there was only white light. After 1 min and 40 s, a tone was
presented for 20 s (80 db, 2000 Hz). During the last 2 s of the tone the mice
received a shock through the grid ﬂoor (0.6 mA). The context testing was
performed 24 h later. The animals were placed in the same box as
previously. The white light was on and the animal was video recorded for
3 min. The cue test was performed 4 h after the context test. The animals
were placed in a sound-proof chamber similar to the training and context
chamber, but with a white inner box instead of the metal one with grid
ﬂoor. When an animal was inside the box, the red light was turned on. The
animal was left in the box for 1 min before the tone was initiated. The tone
(80 dB, 2000 Hz) was on for 2 min after which the animal was left in the
box for another minute. Freezing during training, context test and cue test
was scored manually using the Observer software (Noldus Information
Technologies).
Data and statistical analysis
Statistical tests are indicated in the respective ﬁgure legends. All tests were
carried out in Graphpad Prism (La Jolla, CA, USA) and excel, and Po0.05
was considered statistically signiﬁcant. The three genotypes were generally
compared by one-way or two-way analysis of variances, if the variance did
not differ between the three genotype groups. If the variance did differ
between the three groups, they were compared by the non-parametric
Kruskal–Wallis test. If overall comparison of genotype groups was
signiﬁcant multiple comparisons were computed. Data shown are from
males, unless otherwise stated.
RESULTS
Decreased survival and body weight of Df(h15q13)− /− mice
Expression of deleted genes was examined in whole brain by
quantitative PCR. All six protein-coding genes in the deleted
region were absent in the Df(h15q13)− /− mice, whereas all except
Trpm1, which is not normally expressed in the brain, were
expressed in WT littermates (data not shown).
At birth, the fraction of pups that were homozygous for the
deletion, Df(h15q13), was 0.20; slightly, but signiﬁcantly below the
expected ratio of 0.25 (binomial test, Po0.05). Survival into
adulthood (8 weeks of age) was also reduced, but could be
improved by later weaning and addition of nutritional supple-
ments (Table 2). We observed decreased body weight persisting
into adulthood (Figure 1a), and a small decrease in adult brain
weight of Df(h15q13)− /− mice (Supplementary Figure S1).
Table 2. Df(h15q13)− /− fraction of all animals at weaning and survival into adulthood depends on weaning conditions
Condition At weaning Adulthood
Total − /− − /− Fraction Total − /− − /− Fraction Binomial test
Weaning at 3 weeks 162 19 0.117 147 6 0.041 Po0.001
Weaning at 4 weeks 101 12 0.119 98 11 0.112 P40.05
Weaning at 4 weeks+supplements 403 50 0.124 399 50 0.125 P40.05
At weaning: genotyping at weaning, 3 or 4 weeks after birth. Df(h15q13)− /− fraction compared with birth ratio by binomial test (birth ratio was 0.20).
Adulthood: 8 weeks. Total: total number of mice. − /− : number of Df(h15q13)− /− mice. − /− fraction: Df(h15q13)− /− fraction of mice compared with fraction
at weaning by binomial test. Supplements: nutritional supplements were added to the breeding cages. Pairwise testing probability of survival into adulthood
assuming binomial numbers and using an approximate Gaussian test: weaning at 3 weeks vs weaning at 4 weeks Po0.05, weaning at 3 weeks vs weaning at
4 weeks+supplements Po0.01, weaning at 4 weeks vs weaning at 4 weeks+supplements P40.05.
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Df(h15q13)− /− mice basic behavior
Homozygous Df(h15q13)− /− mice were compared with hemi-
zygous Df(h15q13)+/− and WT littermates in the Irwin test, which
assesses basic behavior and physiological function.13 During
undisturbed observation Df(h15q13)− /− mice had normal body
posture and displayed normal behavior (active, exploring, rearing,
snifﬁng, climbing and grooming). However, some Df(h15q13)− /−
mice displayed repetitive behavior (jumping or crawling in the
corner of the cage). This observation was followed up by a
formalized test in which this repetitive behavior was quantiﬁed
(see later section ‘Df(h15q13)-/- mice exhibit alterations in autism-
related tests’). We found that Df(h15q13)− /− mice had decreased
grip strength and performed less well in the wire maneuver test,
compared with Df(h15q13)+/− and WT littermates (data not
shown). Subsequent quantiﬁcation of grip strength with a Newton
meter conﬁrmed that Df(h15q13)− /− mice had decreased grip
strength (Figure 1b). Df(h15q13)− /− mice were normal in all other
characteristics assessed by the Irwin test; visual placing response,
corneal response, limb and abdominal tone, touch escape, and
responses to tail-pinch, toe-pinch and ﬁnger approach (data not
shown).
To investigate motor activity and anxiety of the Df(h15q13)− /−
mice, they were tested in the open-ﬁeld assay. Df(h15q13)− /−
mice moved the same distance as their WT littermates during the
1-h trial (Figure 1c). Other parameters such as velocity, time spent
in inner, middle or outer zone and so on, did not differ between
genotypes either (data not shown).
Several of the following behavioral assays have been conducted
in more than one batch of animals and in both male and female
mice. Unless otherwise stated, the data shown in the primary
ﬁgures are from the batch of males with most animals, and the
additional data sets are shown in the Supplementary Figures.
Table 3 summarizes the behavioral phenotypes observed in the Df
(h15q13)+/− mice.
Df(h15q13)− /− mice show abnormal susceptibility to PTZ-induced
seizures
To assess seizure susceptibility in the Df(h15q13)− /− mice we
scored four seizure behaviors after pentylene tetrazole (PTZ)
administration; (1) early-stage seizures, (2) myoclonic jerks, (3)
clonic seizures and (4) clonic–tonic seizures.
Early-stage seizures
The Df(h15q13)− /− mice consistently had at least a twofold
increase in time spent in early-stage seizures than their WT litter-
mates. There was also an increase in the time spent in early-stage
seizures for the Df(h15q13)+/− mice compared with WT littermates
(t-test Po0.01), although this was not statistically signiﬁcant when
correcting for multiple testing (Figure 2a and Supplementary
Figures S2A and D).
To clarify if the genotype difference in time in early-stage
seizures was because the WT mice stopped having early-stage
seizure behavior after progressing into clonic seizures, we
compared time spent in early-stage seizures before any of the
animals had developed clonic seizures. During this period the Df
(h15q13)− /− mice also spent more time in early-stage seizures
(Supplementary Figure S3).
Myoclonic jerks
As previously reported, the Df(h15q13)+/− mice had signiﬁcantly
increased propensity for myoclonic jerks compared with WT
littermates after PTZ administration.9 However, the Df(h15q13)− /−
mice had few (Figure 2b and Supplementary Figures S2B and E).
Clonic seizures
We observed increased latency and decreased incidence of clonic
seizures induced by PTZ in Df(h15q13)+/− mice, similar to what
have previously been reported.9 No Df(h15q13)− /− mice had
Table 3. Behavioral phenotypes expressed qualitatively compared
with WT, which is designated ‘0’
WT +/- -/-
Early-stage seizure 0 + ++
Myoclonic jerks 0 +* 0
Clonic seizure 0 − * −−
Repetitive jumping 0 (+) ++
Social preference 0 (+) ++
Ultrasonic vocalization 0 (− )* −−
Nest building 0 − −−
Acoustic startle response 0 − −−
Prepulse inhibition 0 (− ) −−
Cue test (fear conditioning) 0 (− ) −−
Abbreviation: WT, wildtype. Decrease or increase in the Df(h15q13)+/ −
compared with WT, is indicated as ‘− ’ or ‘+’, respectively. Changes that are
not statistically signiﬁcant are indicated in brackets. Stronger decrease or
increase in the Df(h15q13)− /− than Df(h15q13)+/ − is indicated as ‘--’ or
‘++’, respectively. ‘*’ previous reports show a signiﬁcant change in the same
direction for Df(h15q13)+/− mice compared with WT. 9,10
Figure 1. Basic characterization of Df(h15q13)− /− mice. (a) Body weight gain. n= 9–52 for each genotype. Repeated measures ANOVA,
Po0.0001. Tukey’s multiple comparisons indicated. (b) Grip strength measured by Newton meter. n= 4–6 for each genotype. One-way ANOVA,
Po0.01. Tukey’s multiple comparisons indicated. (c) Locomotion was assessed in an open-ﬁeld test. n= 8–11 for each genotype. One-way
ANOVA, NS. Data presented as mean± s.e.m. *Po0.05; **Po0.01; ***Po0.001. ANOVA, analysis of variance; NS, not signiﬁcant; WT, wildtype.
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clonic seizures after PTZ administration, indicating that this
phenotype is also gene-dosage dependent (Figure 2c and
Supplementary Figures S2C and F).
Clonic–tonic seizures
In both the batches of animals 0–33% of the WT mice with clonic
seizures progressed to clonic–tonic seizures, whereas we did not
observe clonic–tonic seizures in any of the Df(h15q13)+/− or Df
(h15q13)− /− mice (data not shown). There was no difference in
PTZ blood levels between genotypes (average = 10651 ng ml− 1,
P= 0.96, measured 1 h after dosing).
We have not observed spontaneous convulsive seizures in
home cages or during behavioral tests.
Df(h15q13)− /− mice exhibit alterations in autism-related tests
Stereotypic repetitive movements, in the form of jumping or
crawling in the corner of the cage were observed in several
homozygotes during the Irwin test and in home cages, primarily
in females. Therefore, this behavior was quantiﬁed, and Df
(h15q13)− /− mice displayed more repetitive crawling or jumping
in the corner of the cage than WT and Df(h15q13)+/− littermates
(Figure 3a). This was replicated in a separate batch of animals and
while the phenotype appeared stronger in female mice a similar
pattern was observed in male mice (Supplementary Figure S4). We
also quantiﬁed other behaviors such as grooming, rearing, digging
and so on, but found no difference between the genotypes (data
not shown).
In order to address social behavior in the Df(h15q13)− /− mice,
we tested them in the three-chambered social approach task.15 All
animals spent more time snifﬁng the cylinder with the novel
mouse compared with the empty cylinder. Df(h15q13)− /− mice
spent 20% more of total snifﬁng time at the cylinder with the
novel mouse than their WT littermates (Figure 3b). There was also
a change in the same direction for the Df(h15q13)+/− mice (t-test,
Po0.05), although this was not statistically signiﬁcant when
accounting for multiple testing. There was no difference in total
snifﬁng time (time spent snifﬁng either of the two cylinders)
between genotypes.
Figure 2. Abnormal seizure response to PTZ in Df(h15q13)− /− mice. Mice received PTZ 40 mg kg− 1 subcutaneously and were observed for
30 min and scored for seizures as described in Materials and Methods. n= 5–7 for each genotype. (a) Time in early-stage seizure. Kruskal–Wallis
test, Po0.05. Dunn’s multiple comparisons induicated. (b) Number of myoclonic jerks during a 30-min period after PTZ administration.
Kruskal–Wallis test, Po0.01. Dunn’s multiple comparisons indicated. (c) Incidence of clonic seizures. Logrank test, Po0.01. WT vs Df
(h15q13)+/− NS, WT vs Df(h15q13)− /− Po0.01, Df(h15q13)+/− vs Df(h15q13)− /− NS. Data (a, b) presented as mean± s.e.m. **Po0.01. NS, not
signiﬁcant; PTZ, pentylene tetrazole; WT, wildtype.
Figure 3. Autistic features in Df(h15q13)− /− mice. (a) Mice were placed in individual cages and observed for 10 min. Quantiﬁcation of
repetitive jumping or crawling in the corner of the cage is shown here. n= 10–13 for each genotype, female mice. Kruskal–Wallis test, Po0.05.
Dunn’s multiple comparisons indicated. (b) Three-chambered social approach task. Social snifﬁng: time spent snifﬁng the cylinder with the
novel mouse. Total snifﬁng time: time spent snifﬁng the cylinder with the novel mouse and the empty cylinder. n = 6–7 females for each
genotype. One-way ANOVA, Po0.01. Tukey’s multiple comparisons indicated. (c) Ultrasonic vocalization in 6-day-old pups. Calls are
normalized to the average number of calls within each litter. n= 6–53 for each genotype. One-way ANOVA, Po0.05. Tukey’s multiple
comparisons indicated. Data presented as mean± s.e.m. *Po0.05; **Po0.01. ANOVA, analysis of variance; WT, wildtype.
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We tested ultrasonic vocalization of Df(h15q13)− /− pups, and
found that they had a twofold decrease in number of vocalizations
Df(h15q13)+/− and WT littermates (Figure 3c). There was also a
trend towards a decrease in vocalization for the Df(h15q13)+/−
mice, although this was not statistically signiﬁcant.
Df(h15q13)− /− mice perform less nest building
We scored nest building in Df(h15q13)− /−, Df(h15q13)+/− and WT
female mice. In a gene-dosage dependent manner, Df(h15q13)
mice performed less nest building than their WT littermates
(Figure 4).
Df(h15q13)− /− mice show alterations in preattentive information
processing
We assessed acoustic startle response at varying intensities, and
PPI of the acoustic startle response in Df(h15q13)− /− mice
compared with Df(h15q13)+/− and WT littermates.
In a gene-dosage-dependent manner Df(h15q13), mice startled
less in response to the acoustic stimulus than WT mice (Figure 5a).
This pattern was seen in both males and females in two separate
batches of animals (Supplementary Figure S5).
Df(h15q13)− /− mice displayed decrease in PPI, that is, impaired
sensorimotor gating, compared to WT littermates (Figure 5b). This
pattern was also seen in both sexes in two separate batches of
animals (Supplementary Figure S6).
Cognition in Df(h15q13)− /− mice
To assess spatial memory in the Df(h15q13)− /− mice, we tested
them in the Morris water maze and compared their performance
with Df(h15q13)+/− and WT littermates. As observed previously,
the Df(h15q13)+/− mice were as good as the WT mice at learning
where the platform was9 (Figure 6a). In contrast, the Df(h15q13)− /−
mice did not learn where the platform was (Figure 6a). In
the subsequent visual trial, where a ﬂag was placed on top of the
platform, the Df(h15q13)+/− mice and WT littermates reached the
platform in about 10 s as seen previously,9 but the Df(h15q13)− /−
mice did not ﬁnd the platform (Figure 6b). It was not clear whether
the inability of the Df(h15q13)− /− mice to learn the location of the
platform was due to cognitive and/or visual impairment.
Therefore, we chose to perform a memory test that does not
rely strongly on vision—the auditory fear-conditioning test.
Contextual fear memory did not differ signiﬁcantly between the
genotypes (Figure 6c). In contrast, auditory cued fear memory was
signiﬁcantly decreased in Df(h15q13)− /− mice compared with WT
littermates. There was a change in the same direction for the Df
(h15q13)+/− mice, although this was not signiﬁcant (Figure 6d).
DISCUSSION
We have shown that Df(h15q13)− /− mice display strong pheno-
types related to epilepsy, autism and schizophrenia. Several of
these phenotypes were also present in the Df(h15q13)+/− mice,
although weaker, indicating a gene-dosage dependency.
Df(h15q13)− /− mice exhibited a strong but complex seizure
threshold phenotype in response to the GABA(A) antagonist PTZ
with increased propensity for early-stage seizures and a decreased
propensity for full clonic seizures. We also found similar, but
weaker effects in mice with hemizygous deletion in accordance
with earlier work.9 In humans, there is also an apparent gene-
dosage effect on seizure phenotypes, as humans with hemizygous
15q13.3 deletion have a highly increased risk of epilepsy, while all
11 humans with homozygous deletion developed epilepsy in early
Figure 5. Auditory sensory processing and –gating deﬁcits in Df
(h15q13)− /− mice. n= 8–11 for each genotype. (a) Progressive startle.
Two-way ANOVA, no signiﬁcant interaction between intensity and
genotype. Main effects of intensity (Po0.0001) and genotype
(Po0.0001). Tukey’s multiple comparisons of genotype groups
indicated. (b) Prepulse inhibition (PPI) at varying prepulse intensities.
Two-way ANOVA, no signiﬁcant interaction between prepulse
intensity and genotype. Main effects of prepulse intensity
(Po0.0001) and genotype (Po0.01). Tukey’s multiple comparisons
of genotype groups indicated. **Po0.01; ****Po0.0001. ANOVA,
anaysis of variance.
Figure 4. Impaired nest building in Df(h15q13)− /− mice. Maximal
score is 8 (see Materials and Methods). n= 6–10 females for each
genotype. Two-way ANOVA, no signiﬁcant interaction between time
and genotype. Main effect of time (Po0.0001) and genotype
(Po0.0001). Tukey’s multiple comparisons indicated. Data pre-
sented as mean± s.e.m. ***Po0.001. ANOVA, analysis of variance;
WT, wildtype.
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childhood. In this context, it may seem unexpected that
spontaneous clonic seizures were not observed in the mice,
which instead display this complex seizure threshold phenotype.
However, human 15q13.3 deletion carriers mainly display absence
seizures and some rat models of absence epilepsy are protected
from clonic seizures.7,8,19,20 Furthermore, the PTZ-induced seizure
assay tests the excitability of neurocircuitry involved in seizures,
but does not directly model epilepsy. We have not observed
spontaneous convulsive seizures; however, it would be relevant in
future studies to examine whether seizures develop in mice older
than 6 months, and whether spontaneous absence seizures
develop as previous EEG studies in hemizygous mice, indicating a
lowered threshold to absence seizures.9 It is striking that seizure-
related alterations are prominent phenotypes in both humans
and mice with the deletion and that they show gene-dosage-
dependent effects in both. Therefore, we think that these
alterations are very likely to be related and that further exploration
of the seizure phenotypes in the mice might provide an
understanding of the epilepsy phenotypes in humans.
We also observed changes relevant to the three hallmarks of
autism; (1) stereotypic repetitive behavior, (2) change in social
behavior, and (3) communication abnormalities.21 The repetitive
jumping that we observed in Df(h15q13)− /− mice indicates that
these mice mimic the restricted and repetitive behaviors seen in
patients suffering from autism. Similarly, the decrease in ultrasonic
vocalization that we observed in Df(h15q13)− /− pups indicates
that the abnormal communication observed in patients suffering
from autism is mirrored in the Df(h15q13)− /− mice.22 For both
repetitive behavior and ultrasonic vocalization we observed
changes in the same direction in Df(h15q13)+/− mice that were
not signiﬁcant after correcting for multiple testing. A previous
report of similar changes in another hemizygous deletion model
further supports that there is an effect in the hemizygotes and
thus a gene-dosage dependent effect on these phenotypes.10 In
contrast, the increase in social snifﬁng that we observed in the
three-chambered social approach assay for Df(h15q13)− /− mice, is
unexpected given the impairment of social behavior characteristic
for patients with autism.21 There was a nonsigniﬁcant trend in the
same direction in Df(h15q13)+/− mice, but this is not supported by
previous work in another hemizygous 15q13.3 deletion mouse
model.10 The three-chambered social-approach assay quantiﬁes
how much time the mice use exploring a novel mouse, which can
be interpreted as social interest, but it does not qualitatively assess
social behavior.23 Thus, it indicates a social behavior abnormality
of Df(h15q13)− /− mice, but further studies are needed to describe
this in detail. The social phenotype of the Df(h15q13)− /− mice
could be further investigated in reciprocal interaction, where
Kogan et al.10 observed decreased social interaction for their
hemizygous 15q13 mouse model.
Nest building has been proposed as a behavior with relevance
to negative symptoms in schizophrenia.24 And we observed a
gene-dosage-dependent nest-building impairment in the Df
(h15q13)− /− and Df(h15q13)+/− mice.17 We also detected a
decrease in acoustic startle response and prepulse inhibition in
Figure 6. Cognition in Df(h15q13)− /− mice. (a, b) Morris water maze. n= 4–6 for each genotype. (a) Acquisition for six consecutive days, four
trials per day, ITI 30 min. Repeated measures ANOVA, Po0.001. Tukey’s multiple comparisons indicated. Mean± s.e.m. (b) Visual trial. Kruskal–
Wallis test, Po0.05. Dunn’s multiple comparisons indicated. (c, d) Fear conditioning. N= 6–9 females for each genotype. (c) Context fear
memory. One-way ANOVA, NS. Mean± s.e.m. (d) Auditory cued fear memory. Kruskal–Wallis test, Po0.05. Dunn’s multiple comparisons
indicated. Data presented as mean± s.e.m. *Po0.05; ***Po0.001. ANOVA, analysis of variance; NS, not signiﬁcant; WT, wildtype.
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Df(h15q13)− /− mice, whereas Df(h15q13)+/− only had decreased
acoustic startle response in accordance with previous character-
ization of the hemizygotes.9 Without direct tests of hearing, it
cannot be ruled out that impaired hearing contribute to this
phenotype in Df(h15q13)-/- mice. However, this ﬁnding further
support the Df(h15q13)− /− mice as a model for aspects of
schizophrenia, as impairments in PPI have been reported in
several psychiatric disorders and particularly in schizophrenia.25
Cognitive disabilities are another relevant group of phenotypes
in relation to both schizophrenia and autism. As a measure of
cognitive function we tested spatial learning and memory in
the Morris water maze test, where Df(h15q13)+/− mice were
previously shown to have a deﬁcit in long-term spatial memory.9
The Df(h15q13)− /− mice were unable to learn the location of the
hidden platform, and were unable to ﬁnd the platform in the
visual test where a ﬂag is placed on top of the platform. Possible
reasons for this might be; (1) cognitive impairments that prevent
the mice from using the visual cues to guide them to the platform,
(2) visual impairments that prevent the mice from seeing the
visual cues and the ﬂag, (3) repetitive movements or absence
seizures and (4) a combination of these. In the present study, we
observed normal visual placing response and corneal response in
the Df(h15q13)− /− mice, so the mice are not blind. However, the
Trpm1 gene in the 15q13.3 region has been linked to deﬁcits in
visual light response,26,27 and mild visual impairment might
prevent the Df(h15q13)− /− mice from detecting the visual cues in
the Morris water maze test. Further assessment of visual function
in the Df(h15q13)− /− mice is needed to elucidate this.
Owing to the difﬁcult interpretation of the Morris water maze
data, we performed a cognitive test that did not rely strongly on
visual function—the fear-conditioning test. In the cue test the Df
(h15q13)− /− mice displayed a deﬁcit in auditory cued fear memory
(Figure 6d), indicating that memory is indeed impaired in Df
(h15q13)− /− mice, consistent with the high penetrance of
intellectual disability in the 15q13.3 microdeletion syndrome.2
For most of the observed behavioral Df(h15q13)− /− phenotypes
there was a similar but less pronounced change in the Df
(h15q13)+/− mice (Table 2). Clear examples of such gene-dosage-
dependent phenotypes were the reduced incidence of PTZ-
induced clonic seizures, impaired nest building and reduced
acoustic startle response. A few phenotypes such as PPI deﬁcits
were only present in the Df(h15q13)− /− mice. Such phenotypes
may be irrelevant to the hemizygous deletion, but considering the
variable phenotype in the human hemizygous microdeletion
syndrome, some may be dependent on interaction with environ-
mental or additional genetic factors. Thus, it could be interesting
to test whether hemizygous Df(h15q13)+/− mice had, for example,
PPI phenotypes if subjected to environmental challenge or bred in
a different genetic background.
It is unknown which gene(s) in the 15q13.3 region that drives
the phenotypes seen in humans and mice affected by the
hemizygous and homozygous microdeletions. CHRNA7 has been
the most popular candidate, as several cases of deletions
encompassing only CHRNA7 have been described in patients
with neuropsychiatric disorders.3,28–30 The characterization of Df
(h15q13)− /− mice allows comparison with mice with single
homozygous gene deletions. Single gene knockout mice have
been described for three of the genes in the 15q13.3 region,
KLF13, TRPM1 and CHRNA7.
Klf13− /− mice are reported as normal overall and do not have
reduced weight like the Df(h15q13)− /− mice.31,32 Klf13− /− mice
characterization has focused on blood composition and no
behavioral tests of the Klf13− /− mice have been described.
Trpm1− /− mice display reduced visual sensitivity to light.26,27 As
Trpm1 is mainly expressed in the retina and essentially not in the
brain, it is unlikely to be a major driver of the behavioral and
physiological phenotypes of the Df(h15q13)− /− mice. However, it
might contribute to the impaired water-maze performance
through effects on vision. Chrna7− /− mice have been thoroughly
studied, but have very subtle phenotypes.33–35 In contrast to Df
(h15q13)− /− mice, Chrna7− /− mice develop normally, have
unaltered seizure threshold, display normal acoustic startle
response and normal prepulse inhibition, do not display deﬁcits
in memory assessed by the Morris water maze and auditory fear-
conditioning tests.35 Consequently, it seems unlikely that Chrna7
alone accounts for the phenotypes that we observed in the Df
(h15q13)+/− and Df(h15q13)− /− mice. Thus, one or more of the
other genes in the region must be important for the phenotypes
in Df(h15q13)− /− mice and by inference in the human 15q13.3
deletion.
In conclusion, the behavioral phenotypes of the Df(h15q13)− /−
mice reported here demonstrate that Df(h15q13)− /− mice are
relevant as a model of both the hemizygous and the rare
homozygous 15q13.3 microdeletion syndromes. The phenotypes
related to epilepsy, autism and schizophrenia that we observed in
the Df(h15q13)− /− mice support that they can be used to explore
how 15q13.3 deletion can lead to these disorders. Importantly, the
Df(h15q13)− /− mice might also be useful for studying the
biological overlap between the disorders.
Mechanistic exploration is much simpler when phenotypes are
strong, and the many gene-dosage-dependent phenotypes
indicate that the Df(h15q13)− /− model may be used to comple-
ment the Df(h15q13)+/− model to explore the underlying biology
of 15q13.3-associated disorders. Currently, the treatment options
for epilepsy, autism and schizophrenia are not optimal and
drug development efforts have been hampered by the lack of
biological understanding of these disorders. If the Df(h15q13)− /−
mice can contribute to a better mechanistic understanding of
biological changes underlying epilepsy, autism and schizophrenia
they might ultimately facilitate drug discovery efforts in relation to
these disorders.
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